Abstract

 

Fertility  preservation  is  a  growing  field  in  reproductive  medicine  that  may  raise  ethical  questions.  Preservation  of  fertility  must  be  discussed  with  the  patient  if  gonadotoxic  treatment  is  required,  whether  in  the  case  of  benign  or  malignant  pathology,  or  in  the  management  of  transgender  identity.  As  a  result,  surgery  or  chemotherapy  that  has  fewer  adverse  impacts  on  fertility  should  be  proposed  if  this  does  not  alter  the  prognosis  of  the  disease.  If  the  risk  of  infertility  persists,  then  fertility  cryopreservation  should  be  proposed  for  children  and  adults  of  re-productive age. Sperm, oocytes, and gonadal tissue can be cryopreserved for many years.  FIGO  wishes  to  emphasize  the  importance  of  fertility  preservation  in  the  medical and surgical management of patients, and the importance of a specialized, multidisciplinary approach.

 

KEYWORDS: female, fertility preservation, male, oocytes, ovarian tissue, sperm, testicular tissue

Read more: https://obgyn.onlinelibrary.wiley.com/doi/epdf/10.1002/ijgo.15187

Source/Copyright: International Federation of Gynecology and Obstetrics (FIGO) January News

 

Twitter